Authors: Meucci VM
, Minunni M
, Vanni M
, Sgorbini M
, Intorre L
Determination of phenylbutazone and flunixin meglumine in horse plasma by electro-chemical-based detection coupled to selective extraction with molecularly imprinted polymers.
Publication date: 2012
Journal: Journal of Veterinary Pharmacology and Therapeutics
Abstract: (Introduction) Phenylbutazone (PBZ) and flunixin meglumine (FXN) are nonsteroidal anti-inflammatory drugs (NSAIDs) with anti-inflammatory and analgesic activity widely used for the treatment of bone and joint inflammations, laminitis and soft tissue inflammation in the horse. PBZ and FXN can also be used in racehorse to mask signs of inflammation and pain and frequently are identified in anti-doping control tests. The aim of the present study was to develop a new, selective, sensitive and fast analytical approach for PBZ and FXN quantitative detection in equine plasma.
Template and target information: Phenylbutazone, PBZ, flunixin meglumine, FXN
Join the Society for Molecular Imprinting
New items RSS feed
View latest updates
Sign-up for e-mail updates:
Choose between receiving an occasional newsletter or more frequent
to go to the sign-up page.
Is your name elemental
? Enter your name and find out by clicking either of the buttons below!
Other products you may like: